Lilly Agrees to Acquire Orna Therapeutics for Up to $2.4B (LYG, ORN)

Lilly (LYG) agreed to acquire Orna Therapeutics (ORN) in a cash transaction valued at up to $2.4 billion, the companies announced Monday, Feb 9, 2026. The acquisition is expected to close in the first half of 2026, pending regulatory approvals and the achievement of certain development milestones. The deal follows Lilly's ongoing expansion into the biotechnology and gene therapy space.